Tech Company Financing Transactions

Predictive BioSciences Funding Round

Predictive BioSciences, based in Lexington, secured $25 million in investment from ProQuest Investments, Flybridge Capital Partners and Highland Capital Partners.

Transaction Overview

Announced On
6/16/2010
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series C
Investors

ProQuest Investments (Lead Investor) (Jay Morin)

Flybridge Capital Partners (Michael Greeley)

Highland Capital Partners (Bijan Salehizadeh)

Kaiser Permanente Ventures

New Enterprise Associates (James Barrett)

Proceeds Purpose
Proceeds from the Series C financing will be used to complete multi-center clinical trials for Predictive's CertNDx bladder cancer assay and support its commercial launch through the company's CLIA certified laboratories.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
128 Spring Street Level B Annex 400 Level
Lexington, MA 02421
USA
Email Address
Overview
Predictive Biosciences is a molecular diagnostics company headquartered in Lexington, MA. Launched in 2006 with a $10 million Series A financing, the company was jointly founded by leading healthcare investors.
Profile
Predictive BioSciences LinkedIn Company Profile
Social Media
Predictive BioSciences Company Twitter Account
Company News
Predictive BioSciences News
Facebook
Predictive BioSciences on Facebook
YouTube
Predictive BioSciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Pierre Cassigneul
  Pierre Cassigneul LinkedIn Profile  Pierre Cassigneul Twitter Account  Pierre Cassigneul News  Pierre Cassigneul on Facebook
Chief Medical Officer
Angelo Marzo
  Angelo Marzo LinkedIn Profile  Angelo Marzo Twitter Account  Angelo Marzo News  Angelo Marzo on Facebook
Chief Technical Officer
Anthony Shuber
  Anthony Shuber LinkedIn Profile  Anthony Shuber Twitter Account  Anthony Shuber News  Anthony Shuber on Facebook
VP - Sales
Mark Girardi
  Mark Girardi LinkedIn Profile  Mark Girardi Twitter Account  Mark Girardi News  Mark Girardi on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/16/2010: AlienVault venture capital transaction
Next: 6/16/2010: GTC Biotherapeutics venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We report on tech company VC transactions. All VC database entries on this site are derived from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary